Abstract
The results can be used to improve the pathogenetic therapy of autoimmune thyroiditis. Goal. To set the immune status features in women with autoimmune thyroiditis (AIT) depending on prolactin levels (PRL). Material and methods. 90 women with AIT and subcompensated hypothyroidism were examined: basal levels of PRL, thyroid-stimulating hormone (TSH), and free thyroxine (fT4) were studied. In subgroups with hyper- and normoprolactinemia (GPRL, NPRL), the immunophenotype of lymphocytes (CD3, CD4, CD8, CD16, CD22), the level of antithyroid antibodies to thyroglobulin (ATTG) and thyroperoxidase (ATTPO) were studied. Results. GPRL occurred in 35.5% of cases, its presence was accompanied by more pronounced hypothyroidism (p <0.05 to increase the level of TSH
and p <0.05 to decrease fT4) compared with the group with NPRL. All studied parameters of cellular immunity, as well as AbTPO in the group with GPRL were significantly higher than with NPRL. Reliable associative relationships between PRL and indicators of cellular immunity, as well as AbTPO, have been established. Conclusions. The presence of hyperprolactinemia in patients with AIT reduces the effectiveness of thyroid replacement therapy for hypothyroidism. Hyperprolactinemia can be regarded as a stimulant of the immunopathogenetic link in autoimmune thyroiditis. Prolactin is associated
with level increassion of T-, B-lymphocytes, natural killer cells and helps to increase the synthesis of antithyroid antibodies.
References
Elenkova A, Petrossians P, Zacharieva S, Beckers A. High prevalence of autoimmune thyroid diseases in patients with prolactinomas: a cross-sectional retrospective study in a single tertiary referral centre. In Annales d’endocrinologie. 2016;77(1):37-42.
Строев ЮИ, Чурилов ЛП. Случай бесплодного брака, связанной с аутоиммунным тиреоидитом и клинически бессимптомной макроаденомой гипофиза (пролактиномой). Клиническая патофизиология. 2016;22(1):72-79. (Stroev YuI., Churilov LP. A case of infertile marrige related to autoimmune thyroiditis and clinically latent pituitary macroadenoma (prolactinoma). Clinical pathophysiology. 2016;1:72-79).
Иванова ГП, Горобец ЛН. Психоэндокринные аспекты проблемы хронического аутоиммунного тиреоидита у женщин репродуктивного возраста. Журнал неврологии и психиатрии им. С.С. Корсакова. 2010;110(1):33-41. (Ivanova GP, Gorobets LN. Psychoendocrinological aspects of chronic autoimmune thyroiditis in women of reproductive age. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(1):33-41).
Сохадзе ХС, Сабуров АВ, Гаврилова НП. Реализация программы вспомогательных репродуктивных технологий у женщин с гиперпролактинемией и дисфункцией щитовидной железы. Фундаментальные исследования. 2013;9-4:734-743. (Sokhadze KS, Saburov AV, Gavrilova NP. Implementation
of the assisted reproductive technology program in women with hyperprolactinemia and thyroid dysfunctions. Fundamental research. 2013;9(part 4):734-743).
Ben-Jonathan N, LaPensee CR, LaPensee EW. What can we learn from rodents about prolactin in humans? Endocr. Rev. 2008;29:1-41.
Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Rachelle Donn R, Ollier WER, Worthington J, Davis JRE. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum. 2001;44(10):2358-2366.
Али Н, Каледина ЕА, Петяева АВ, Строев ЮИ, Чурилов ЛП. Гиперпролактинемия и аутоиммунитет. Клиническая патофизиология. 2018;3:27-38. (Ali N, Kaledina E, Petyaeva A, Stroev Yu, Churilov L. Hyperprolactinemia and autoimmunity. Clinical pathophysiology. 2018;4:30-37).
Tripathi A, Sodhi A. Production of nitric oxide by murine peritoneal macrophages in vitro on treatment with prolactin and growth hormone: involvement of protein tyrosine kinases, Ca(++), and MAP kinase signal transduction pathways. Mol. Immunol. 2007;44:3185-3194.
Tripathi A, Sodhi A. Prolactin-induced production of cytokines in macrophages in vitro involves JAK/STAT and JNKMAPK pathways. Int. Immunol. 2008;20:327-346.
Carreno PC, Jimenez E, Sacedon R, Vicente A, Zapata AG. Prolactin stimulates maturation and function of rat thymic dendritic cells. J. Neuroimmunol. 2004;153:83-90.
Sun R, Li AL, Wei HM, Tian ZG. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines. Cell. Res. 2004;14:67-73.
Попова ЕВ, Тиньков АА, Никаноров АА, Попова ЮВ, Караулов АВ. Влияние пролактина на иммунитет при стрессе. Иммунопатология, аллергология, инфектология. 2016;1:14-19. (Popova EV, Tinkov AA, Nikonorov AA, Popova YV, Karaulov AV. Influence of prolactin into immunity in stress. International journal
of immunopathology, allergology, infectology. 2016;1:14-19).
Orbacha H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun. Rev. 2007;6(I.8):537-542.
Строев ЮИ, Чурилов ЛП. Эндокринология подростков — СПб: Эл-Би-СПб, 2004. — С. 119-207. (Stroyev Yu L, Churilov LP. The Endocrinology of the Adolescents.ELBI-SPbSU, 2004:119-207).
Шабанова СШ, Алекберова ЗС. Нейроэндокринология и аутоиммунитет — современные перспективы. Научн-практ. ревматол. 2010;1:24-31. (Shabanova SSh, Alekberova ZS. Neuroendocrinology and autoimmunity: current aspects. Rheumatology Science and Practice. 2010;48(1):24-31).
Субхангулов ЗМ, Давлетшин РА, Давлетшина ГК, Сафина АЗ. Пролактин и его взаимоотношение с цитокинами при аутоиммунном тиреоидите. Иммунол и клин иммунол. 2007;28(5):300-303. (Subhangulov Z, Davletshin R, Davletshina A. Prolactin and its relationship with cytokines in autoimmune thyroiditis. Immunology. 2007:28(5):300-303).
Максимова АВ, Пинигина ЮИ, Строев ЮИ, Чжао Ваньлун, Чурилов ЛП. Аутоиммунный тиреоидит Хасимото, гипотиреоз, пролактин и женская репродуктивная система. Актуальные пробл. транспортной медицины. 2011;2(24):122-130. (Maximova AV, Pinigina YuI, Stroev YuI, Zhao W, Churilov LP.
Hashimoto’s autoimmune thyroiditis, hypothyroidism, prolactin and the female reproductive system. Actual problems of transport medicine. 2011;2:122-130).
Али Нурин Петяева АВ, Каледина ЕА, Строев ЮП, Чурилов ЛП. Гиперпролактинемия и аутоиммунитет. Клин. патофизиология. 2018;24(3):27-39. (Ali N, Kaledina EA, Petyaeva AV, Stroev YI, Churilov LP. Hyperprolactinemia and autoimmunity. Clinical pathophysiology. 2018;3:27-39).